Vancouver type B periprosthetic femoral fractures (PFF) are challenging complications after total hip arthroplasty (THA), and some treatment controversies remain. The objectives of this study were: to evaluate the short-to-mid-term clinical outcomes after treatment of Vancouver type B PFF and to compare postoperative outcome in subgroups according to classifications and treatments; to report the clinical outcomes after conservative treatment; and to identify risk factors for postoperative complications in Vancouver type B PFF. A total of 97 consecutive PPFs (49 males and 48 females) were included with a mean age of 66 years (standard deviation (SD) 14.9). Of these, 86 patients were treated with surgery and 11 were treated conservatively. All living patients had a minimum two-year follow-up. Patient demographics details, fracture healing, functional scores, and complications were assessed. Clinical outcomes between internal fixation and revisions in patients with or without a stable femoral component were compared. Conservatively treated PPFs were evaluated in terms of mortality and healing status. A logistic regression analysis was performed to identify risk factors for complications.Aims
Methods
US payers offer incentives to hospitals to report patient-reported outcomes measures (PROMs) for total hip arthroplasty (THA). We report THA norms for pre-op and one-year PROMs in a large multi-center cohort and compare global, hip specific scores, and abbreviated PROM measures acceptable to meet payer requirements. The HOOS 12 is a new form of the HOOS containing 12 questions that allows separate determination of pain and ADL sub-scores in addition to the total score. Between 2011–2015, 7895 primary elective THA patients enrolled in the FORCE-TJR research consortium from over 200 surgeons in 28 states. Patients completed pre-op demographics, clinical risks, PROMs, and one-year outcomes. Over 95% completed pre-op PROMs; 83% post-op. Generic and hip specific (HOOS full and HOOS-12 sub-scores, and HOOS JR global) PROMs were compared.Introduction
Methods
Historically, US arthroplasty revision rates are based on CMS data that cannot verify initial surgery date in patients under 65 years or laterality of revision. We calculated US one-year revision rates for primary total hip replacement (THR) using a representative cohort. Reasons for revision were documented. A multi-center cohort from US surgeons in 28 states collected sociodemographic data; medical, emotional, musculoskeletal comorbidities; BMI; and patient-reported pain and function (SF36, HOOS) for elective THR patients. Cases in 2011–2013 were matched with CMS data to ascertain 1 year revision through 2014. Predictors of revision were identified. Chart reviews to verify reasons for revision were performed.Introduction
Methods
